Health Products

Recall of Cannabis for Medical Purposes - Aphria

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Labelling and Packaging
Audience: General Public
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberTelephoneBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
The following lots are classified under the Type III recall initiated on March 8, 2017.1-844-427-4742
Marketing Authorization Holder
Not Applicable
Dried marijuana
Recalling Firm
Aphria
CANADA
Not ApplicableNot Applicable22.3% THC

Introduction

Introduction

On March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. The affected lot number can be found below.

Reason

On March 8, 2017, Aphria initiated a voluntary Type III recall for one lot of product due to the mislabelling of the delta-9-tetrahydrocannabidiol (THC) content of the products. The THC content identified on the label was higher than the concentration present in the products. The products were mislabelled as containing 22.3% THC instead of 21.1% THC.

A Type III recall refers to a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences.

To date, Health Canada has not received any adverse reaction reports for products sold by Aphria. However, Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number 1-844-427-4742.

Media enquiries

Santé Canada
(613) 957-2983
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime